IP Library Granted Patent US 9,688,671
Granted Patent B2
US 9,688,671 · App. 14/897,331 · Granted Jun 27, 2017

Metalloenzyme inhibitor compounds

Inventors: William J. Hoekstra (Durham, NC); Christopher M. Yates (Raleigh, NC)
Assignee: Viamet Pharmaceuticals, Inc.
C07D413/14A01N43/713A01N43/84A01N43/86A61K31/4439A61K31/496A61K45/06C07D401/06C07D401/14C07D409/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,688,671
App. No.
14/897,331
Granted
Jun 27, 2017
Kind
B2
Abstract

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.

Claims (279)

1. A compound of formula (XVI), or salt thereof, wherein:

R 1 is fluoro;

R 2 is fluoro;

each R 4 is independently aryl substituted with 0, 1, 2 or 3 independent R 8 ;

R 5 is H, alkyl, phosphato, phosphito, alkoxyphosphato, or —C(O)alkyl optionally substituted with 1 or 2 amino;

each R 8 is independently optionally substituted alkyl, cyano, haloalkyl, alkoxy, halo, or haloalkoxy;

each R 35 is independently

each X is independently O or S;

each Y is independently OH, NH 2 , or NH—SO 2 —R 17 ;

each n is independently 1, 2, or 3;

each o is independently 0, 1, 2, or 3;

each p is independently 0, 1, 2, or 3;

each t is independently 0, 1, 2, or 3;

each R 14 is independently:

a) alkyl substituted with 1, 2, or 3 independent OH, haloalkoxy, optionally substituted heterocyclo, optionally substituted heteroaryl,

b) alkoxy substituted with 0, 1, 2, or 3 independent OR 17 or

c)

or

d) optionally substituted heterocyclo;

each R 32 is independently:

a) haloalkyl;

b) halo;

c) alkyl substituted with 0, 1, 2, or 3 independent OH, haloalkoxy, optionally substituted heterocyclo, optionally substituted heteroaryl,

or

d)

each R 16 is independently:

a) aralkyl substituted with 0, 1, 2, or 3 independent:

(1) cyano;

(2) halo;

(3)

(4) alkoxy;

(5) haloalkyl;

(6) haloalkoxy;

(7) optionally substituted alkyl;

(8) optionally substituted aryl;

(9) optionally substituted heteroaryl; or

(10) optionally substituted heterocyclyl;

b) OR 17 ; or

c) optionally substituted aryl;

each R 17 is independently H, optionally substituted alkyl, haloalkyl, or

each R 18 is independently:

a) aryl substituted with 0, 1, 2, or 3 independent:

(1) halo;

(2) haloalkyl;

(3) alkoxy;

(4) haloalkoxy;

(5) optionally substituted cycloalkyl;

(6) optionally substituted heterocyclyl;

(7) optionally substituted alkyl;

(8)

(9) OR 19 ;

(10) SR 19 ;

(11) optionally substituted heteroaryl; or

(12) cyano;

b) optionally substituted cycloalkyl;

c) optionally substituted heteroaryl;

d) optionally substituted heterocyclyl;

e) optionally substituted alkyl;

f) optionally substituted cycloalkylalkyl;

g) optionally substituted cycloalkylalkoxy;

h) haloalkyl;

i) haloalkoxy;

j) haloalkoxyalkyl;

k)

or

l) optionally substituted aralkyl;

each R 19 is independently H, optionally substituted alkyl, or haloalkyl;

each R 20 is independently H, optionally substituted alkyl, or

each R 33 is independently H, optionally substituted heteroaryl, optionally substituted alkyl,

optionally substituted haloalkyl, optionally substituted alkylcarbonyl, or

each R 22 is independently:

a)

b) optionally substituted alkyl;

c) optionally substituted aryl;

d) optionally substituted heteroaryl;

e) optionally substituted cycloalkyl; or

f) optionally substituted heterocyclyl; and

each R 25 is independently optionally substituted aryl; optionally substituted arylalkyl, haloalkoxy, (haloalkoxy)alkyl, cycloalkyl, alkyl, —CH 2 CF 2 CF 3 , —CF 2 CF 3 , or

2. A compound of formula (VII), or salt thereof, wherein:

R 1 is halo;

R 2 is halo;

each R 27 is independently alkyl, cycloalkyl, or aralkyl, each substituted with 0, 1, 2 or 3 independent R 8 ;

R 5 is H, alkyl, phosphato, phosphito, alkoxyphosphato, or —C(O)alkyl optionally substituted with 1 or 2 amino;

each R 8 is independently optionally substituted alkyl, cyano, haloalkyl, alkoxy, halo, or haloalkoxy;

each R 30 is independently

each X is independently O or S;

each Y is independently OH, NH 2 , or NH—SO 2 —R 17 ;

each n is independently 0, 1, 2, or 3;

each o is independently 0, 1, 2, or 3;

each p is independently 0, 1, 2, or 3;

each t is independently 0, 1, 2, or 3;

each R 31 is independently:

a) alkyl substituted with 1, 2, or 3 independent OH, haloalkoxy, optionally substituted heterocyclo, optionally substituted heteroaryl,

b) alkoxy substituted with 0, 1, 2, or 3 independent OR 17 or

c)

d) halo;

e) haloalkyl;

f) haloalkoxy; or

g) optionally substituted heterocyclo;

each R 32 is independently:

a) haloalkyl;

b) halo;

c) alkyl substituted with 0, 1, 2, or 3 independent OH, haloalkoxy, optionally substituted heterocyclo, optionally substituted heteroaryl,

or

d)

or

e) haloalkoxy;

each R 16 is independently:

a) aralkyl substituted with 0, 1, 2, or 3 independent:

(1) cyano;

(2) halo;

(3)

(4) alkoxy;

(5) haloalkyl;

(6) haloalkoxy;

(7) optionally substituted alkyl;

(8) optionally substituted aryl;

(9) optionally substituted heteroaryl; or

(10) optionally substituted heterocyclyl;

b) OR 17 ; or

c) optionally substituted aryl;

each R 17 is independently H, optionally substituted alkyl, haloalkyl, or

each R 18 is independently:

a) aryl substituted with 0, 1, 2, or 3 independent:

(1) halo;

(2) haloalkyl;

(3) alkoxy;

(4) haloalkoxy;

(5) optionally substituted cycloalkyl;

(6) optionally substituted heterocyclyl;

(7) optionally substituted alkyl;

(8)

(9) OR 19 ;

(10) SR 19 ;

(11) optionally substituted heteroaryl; or

(12) cyano;

b) optionally substituted cycloalkyl;

c) optionally substituted heteroaryl;

d) optionally substituted heterocyclyl;

e) optionally substituted alkyl;

f) optionally substituted cycloalkylalkyl;

g) optionally substituted cycloalkylalkoxy;

h) haloalkyl;

i) haloalkoxy;

j) haloalkoxyalkyl;

k)

or

l) optionally substituted aralkyl;

each R 19 is independently H, optionally substituted alkyl, or haloalkyl;

each R 20 is independently H, optionally substituted alkyl, haloalkyl, or

each R 33 is independently H, optionally substituted heteroaryl, optionally substituted alkyl, optionally substituted haloalkyl, optionally substituted alkylcarbonyl, or

each R 22 is independently:

a)

b) optionally substituted alkyl;

c) optionally substituted aryl;

d) optionally substituted heteroaryl;

e) optionally substituted cycloalkyl; or

f) optionally substituted heterocyclyl; and

each R 25 is independently optionally substituted aryl; optionally substituted arylalkyl, haloalkoxy, (haloalkoxy)alkyl, cycloalkyl, alkyl, —CH 2 CF 2 CF 3 , —CF 2 CF 3 , or

3. A compound of formula (XV), or salt thereof, wherein:

each R 4 is independently aryl substituted with 0, 1, 2 or 3 independent R 8 ;

R 5 is H, alkyl, phosphato, phosphito, alkoxyphosphato, or —C(O)alkyl optionally substituted with 1 or 2 amino;

each R 8 is independently optionally substituted alkyl, cyano, haloalkyl, alkoxy, halo, or haloalkoxy;

each R 36 is independently

each n is independently 1, 2, or 3;

each p is independently 0, 1, 2, or 3;

each R 37 is independently halo, haloalkyl, or haloalkoxy:

each R 38 is independently:

a) alkyl substituted with 1, 2, or 3 independent OH, haloalkoxy, optionally substituted heterocyclo, optionally substituted heteroaryl,

b) alkoxy substituted with 0, 1, 2, or 3 independent OR N or

c)

or

d) optionally substituted heterocyclo;

each R 17 is independently H, optionally substituted alkyl, haloalkyl, or

each R 19 is independently H, optionally substituted alkyl, or haloalkyl;

each R 33 is independently H, optionally substituted heteroaryl, optionally substituted alkyl,

optionally substituted haloalkyl, optionally substituted alkylcarbonyl, or

4. The compound of claim 1 , wherein R 5 is H.

5. The compound of claim 1 , wherein R 5 is amino substituted acyl.

6. The compound of claim 1 , wherein R 5 is phosphato.

7. The compound of claim 1 , wherein n is 1 and R 35 is at the 4-position of the phenyl ring within formula XVI from claim 1 .

8. The compound of claim 2 , wherein n is 1 and R 30 is at the 4-position of the phenyl ring within formula VII from claim 2 .

9. The compound of claim 3 , wherein R 36 is at the 4-position of the phenyl ring within formula XV from claim 3 .

10. The compound of claim 1 , which is one of:

4-(2-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-2-oxoethyl)benzonitrile (1);

4-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)benzylamino)benzonitrile (2);

2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-((2,2,2-trifluoroethylamino)methyl)phenyl)ethynyl)pyridin-2-yl)propan-2-ol (3);

1-(5-((4-(4-(aminomethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (4);

2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-((5-(trifluoromethyl)thiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)propan-2-ol (5);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-((5-fluorothiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (6);

1-(5-((4-((4-chlorophenylamino)methyl)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (7);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-((4-fluorophenylamino)methyl)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (8);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(hydroxymethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (9);

2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-(4-((2,2,2-trifluoroethoxy)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)propan-2-ol (10);

2-(2,4-difluorophenyl)-1-(5-((4-(4-((dimethylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (11);

N-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)acetamide (12);

1-(5-((4-(4-((1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (13);

2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-(4-((2,2,2-trifluoroethylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)propan-2-ol (14);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(2-hydroxyethoxy)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (15);

2-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)phenoxy)acetic acid (16);

4-(2-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-2-oxoethyl)-2-fluorobenzonitrile (17);

1-(5-((4-((4-(difluoromethyl)phenylamino)methyl)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (18);

2-(4-chloro-3-fluorophenyl)-1-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)ethanone (19);

2-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzylamino)acetic acid (20);

2-(2,4-difluorophenyl)-1-(5-((4-(4-((ethylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (21);

22-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((methylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (22);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(pyrrolidin-1-ylmethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (23);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((oxazol-2-ylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (24);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(1-hydroxyethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (25);

2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-((4-(4-(2,2,2-trifluoro-1-hydroxyethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)propan-2-ol (26);

2-(2,4-difluorophenyl)-1-(5-((4-((5-((dimethylamino)methyl)thiophen-3-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (27);

1-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-2-(4-((dimethylamino)methyl)phenyl)ethanone (28);

1-(5-((4-(4-((2,2-difluoroethoxy)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (29);

2-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyloxy)acetonitrile (30);

2-(2,4-difluorophenyl)-1-(5-((4-((4-((dimethylamino)methyl)phenylamino)methyl)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (31);

2-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzylamino)acetonitrile (32);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)-1H-pyrazole-4-carbonitrile (33);

1-(5-((4-(4-((3-chloro-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (34);

1-(5-((4-(4-((4-chloro-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (35);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((4-fluoro-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (36);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((4-(2-methoxyethyl)-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (37);

N-((1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)-1H-pyrazol-3-yl)methyl)acetamide (38);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((4-(2-hydroxypropan-2-yl)-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (39);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((4-(1-hydroxyethyl)-1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (40);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)-1H-pyrazole-4-carboxylic acid (41);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((methyl(oxazol-2-yl)amino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (42);

2-((4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)(methyl)amino)acetonitrile (43);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((methyl(2,2,2-trifluoroethyl)amino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (44);

1-(5-((4-(4-(((2,2-difluoro-2-hydroxyethyl)(methyl)amino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (45);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(((2-hydroxy-2-methylpropyl)(methyl)amino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (46);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(((2-hydroxypropyl)(methyl)amino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (47);

2-((4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzylamino)methyl)-1H-imidazole-1-carbaldehyde (48);

2-(((4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)(methyl)amino)methyl)-1H-imidazole-1-carbaldehyde (49);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)-1H-imidazole-4-carbonitrile (50);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)-N-methyl-1H-imidazole-2-carboxamide (51);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-((4-methylpiperazin-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (52);

4-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)piperazine-1-carbaldehyde (53);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(morpholinomethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (54);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)imidazolidin-2-one (55);

1-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzyl)imidazolidine-2,4-dione (56);

1-(5-((4-(4-(1-(1H-pyrazol-1-yl)ethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (57);

4-(2-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-2-hydroxyethyl)benzonitrile (58);

4-(4-((4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)phenyl)-1-((S)-2-methylpentan-3-yl)-1H-1,2,4-triazol-5(4H)-one (59);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(4-(2-hydroxy-1-(1H-pyrazol-1-yl)ethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (60);

2-(2,4-difluorophenyl)-1-(5-((4-(4-(1-(dimethylamino)-2-hydroxyethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (61);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(3-(hydroxymethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (62);

2-(2,4-difluorophenyl)-1-(5-((4-(3-((dimethylamino)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (63);

1-(5-((4-(3-((1H-pyrazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (64);

2-(2,4-difluorophenyl)-1-(5-((4-(3-(1-(dimethylamino)-2-hydroxyethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (65);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(3-(2-hydroxy-1-(1H-pyrazol-1-yl)ethyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (66);

1-(5-((4-(3-((3-chloro-1H-1,2,4-triazol-1-yl)methyl)benzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (67);

2-(2,4-difluorophenyl)-1-(5-((4-((5-((dimethylamino)methyl)thiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (68);

1-(5-((4-((5-((1H-pyrazol-1-yl)methyl)thiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (69);

1-(5-((4-((5-(difluoromethyl)thiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (73);

1-(5-((4-((5-chlorothiophen-2-yl)methoxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (74);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-((4-chlorophenyl)(hydroxy)methyl)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (79);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(2-(4-chlorophenyl)-1-hydroxyethyl)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (80);

2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-((4-(1-hydroxy-2-(2,2,2-trifluoroethoxy)ethyl)phenyl)ethynyl)pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ol (81);

1-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-3,3,4,4,4-pentafluorobutan-1-ol (82);

1-(5-((4-(1-amino-2,2,3,3,3-pentafluoropropyl)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (83);

N-(1-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)propyl)-1,1,1-trifluoromethanesulfonamide (84);

1-(4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenyl)-3-(dimethylamino)-2,2-difluoropropan-1-ol (85);

1-(5-((4-(cyclopropyl(hydroxy)methyl)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (86); or a salt thereof.

11. The compound of claim 2 , which is one of:

4-((4-((6-(2-((1H-tetrazol-1-yl)methyl)-1,1-difluoro-2-hydroxy-3-methylbutyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzonitrile (70);

4-((4-((6-(2-((1H-tetrazol-1-yl)methyl)-1,1-difluoro-2-hydroxy-3,3-dimethylbutyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzonitrile (71);

4-((4-((6-(2-cyclopropyl-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)ethynyl)phenoxy)methyl)benzonitrile (72); or a salt thereof.

12. The compound of claim 3 , which is one of:

2-(2,4-difluorophenyl)-1-(5-((4-(4-((dimethylamino)methyl)-3-fluorobenzyloxy)phenyl)ethynyl)pyridin-2-yl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (75);

1-(5-((4-(4-(difluoromethyl)-3-fluorobenzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (76);

1-(5-((4-(4-((1H-pyrazol-1-yl)methyl)-3-fluorobenzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (77);

1-(5-((4-(4-((4-chloro-1H-pyrazol-1-yl)methyl)-3-fluorobenzyloxy)phenyl)ethynyl)pyridin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)propan-2-ol (78); or a salt thereof.

13. A composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

14. The composition of claim 13 further comprising a therapeutic agent in addition to the compound of formula (XVI).

15. The composition of claim 13 further comprising a therapeutic agent in addition to the compound of formula (XVI) wherein said therapeutic agent is an anti-cancer agent, antifungal agent, cardiovascular agent, anti-inflammatory agent, chemotherapeutic agent, an anti-angiogenesis agent, cytotoxic agent, an anti-proliferation agent, metabolic disease agent, ophthalmologic disease agent, central nervous system (CNS) disease agent, urologic disease agent, or gastrointestinal disease agent.

16. A method of inhibiting metalloenzyme activity comprising contacting a compound of claim 1 with a metalloenzyme.

17. The method of claim 16 , wherein the contacting is in vivo.

18. The method of claim 16 , wherein the contacting is in vitro.

19. A method of treating a subject suffering from a metalloenzyme-related disorder or disease, comprising administering to the subject an effective amount of a compound of claim 1 .

Assignments (3)
CHANGE OF NAME Recorded Mar 28, 2018
From: VIAMET PHARMACEUTICALS (NC), INC.
To: MYCOVIA PHARMACEUTICALS, INC.
Reel/Frame 045759/0728 →
CHANGE OF NAME Recorded Jan 2, 2018
From: VIAMET PHARMACEUTICALS, INC.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044978/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: HOEKSTRA, WILLIAM J.; YATES, CHRISTOPHER M.
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 037704/0548 →
Continuity (2)
Provisional Application 61834324 · Jun 12, 2013
Related Publication 20160130263A1 · May 12, 2016